Skip to content

Drug interactions

Elagolix + Vinorelbine

Severity: Moderate

Elagolix and Vinorelbine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix is a weak-to-moderate CYP3A4 inducer and could lower vinorelbine concentrations. The clinical effect is uncertain but could reduce efficacy.

What this interaction means in plain words

Elagolix and Vinorelbine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Elagolix belongs to Musculoskeletal; Vinorelbine belongs to Oncology.

Evidence level: Low

Why it happens

Elagolix induces CYP3A4, increasing vinorelbine metabolism.

What to do

Review the need for elagolix during chemotherapy and consider alternatives. If used, monitor response to vinorelbine.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elagolix and Vinorelbine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elagolix with Vinorelbine?

MediHelp rates the interaction as moderate. Elagolix and Vinorelbine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Elagolix is a weak-to-moderate CYP3A4 inducer and could lower vinorelbine concentrations. The clinical effect is uncertain but could reduce efficacy.

How serious is the interaction between Elagolix and Vinorelbine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Review the need for elagolix during chemotherapy and consider alternatives. If used, monitor response to vinorelbine.

What other medicines interact with Vinorelbine?

MediHelp also lists interactions of Vinorelbine with, for example, Adenovirus types 4 and 7 live, Apalutamide, Belatacept. The full list is on the Vinorelbine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in